IBD Market Snapshot: Payers May Shift Preferred Products To Accommodate New Drugs

Head-To-Head Studies Are Few, But Data Could Change Positioning

IBD on a blue background with medical neon icons, medical background with a microscope, science, research
Payer preferences in IBD could shuffle as new data emerge • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category